Another example of unmoored valuations. This company is founded by someone who has previously had success with health care startups, so the assumption is he will be again. Not necessarily a good investment approach. $58 million in new capital, valuing the company at $500 million, for helping employer health plans provide health "navigation" services.
Hospitals are an expensive health care setting, so for decades policy has attempted to lessen hospital use, which has some unintended consequences, as revealed by the epidemic. One emerging trend has been "hospital at home", in which all the expensive equipment is placed, and monitoring of a patient is literally done, at their home. Mayo Clinic and Kaiser have both invested in a company facilitating hospital at home capabilities, putting as much as $100 million into Medically Home Group.
Vida Health comes alive with a $110 million capital raise to support its business of offering apps to help manage chronic health conditions. It only competes with a hundred other companies offering the same low value crap, so you can understand why investors jumped at the chance to put more money in.
Collective Health aggregates $280 million in new financing to support its employer health benefits management business. The investors have lost their collective minds. The company serves employers with 300,000 members in 55 companies, so it is being valued at about $1000 a member for a commodity business.
Another typical post. For new readers, this blog usually is all health care business, policy, and research and one staple is me making fun of the ridiculous names people put on their start-up health care companies. Wellth, which uses behavioral economics to encourage better treatment plan aherence, has raised $10 million in new financing. Now normally I would find a pun or something that I at least think is clever about that name, but right now I am multi-tasking listening to the daily coronavirus briefing, and that is just depressing.
Fruit Street goes bananas, becoming the apple of investor's eyes and raising a fresh $17 million in financing for its diabetes prevention program. Hope investors don't end up with sour grapes. Orange you glad I did this post.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].